INNOVATION1 BIOTECH INC.: 10-Q filed 2022-07-14

Name: INNOVATION1 BIOTECH INC.: 10-Q filed 2022-07-14
Creator: INNOVATION1 BIOTECH INC.

What INNOVATION1 BIOTECH INC. reported in its quarterly report filed 2022-07-14 (fiscal Q3 2022): 34 published measures, 107 facts as tagged in accession 0001477932-22-005101.

This filing

Form: 10-Q (quarterly report)
Filed: 2022-07-14
Fiscal period: fiscal Q3 2022
Accession: 0001477932-22-005101 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INNOVATION1 BIOTECH INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2022-05-31	81,162,939	USD
At 2021-08-31	181,886	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2022-05-31	40,873,763	USD
At 2021-08-31	406,725	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2022-05-31	40,289,176	USD
At 2022-02-28	42,086,623	USD
At 2021-11-30	44,053,248	USD
At 2021-08-31	-224,839	USD
At 2021-05-31	-42,099	USD
At 2021-02-28	-2,382,475	USD
At 2020-11-30	-2,927,850	USD
At 2020-08-31	-2,678,007	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2022-05-31	636,159	USD
At 2021-08-31	137,476	USD
At 2021-05-31	31,202	USD
At 2020-08-31	17,881	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2022-03-01 to 2022-05-31	-1,609,876	USD	92
2021-09-01 to 2022-05-31	-3,628,782	USD	273
2021-12-01 to 2022-02-28	-1,779,054	USD	90
2021-09-01 to 2021-11-30	-239,853	USD	91
2021-03-01 to 2021-05-31	796,156	USD	92
2020-09-01 to 2021-05-31	1,116,837	USD	273
2020-12-01 to 2021-02-28	557,950	USD	90
2020-09-01 to 2020-11-30	-237,268	USD	91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2021-09-01 to 2022-05-31	-2,648,179	USD	273
2020-09-01 to 2021-05-31	13,321	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2021-09-01 to 2022-05-31	3,138	USD	273
2020-09-01 to 2021-05-31	0	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2022-03-01 to 2022-05-31	0	USD	92
2021-09-01 to 2022-05-31	0	USD	273
2021-03-01 to 2021-05-31	0	USD	92
2020-09-01 to 2021-05-31	3,080	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2021-09-01 to 2022-05-31	4,000,000	USD	273
2020-09-01 to 2021-05-31	0	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2021-09-01 to 2022-05-31	-853,138	USD	273
2020-09-01 to 2021-05-31	0	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2022-05-31	-7,114,440	USD
At 2021-08-31	-2,973,628	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2022-03-01 to 2022-05-31	20,020,239	shares	92
2021-09-01 to 2022-05-31	15,225,781	shares	273
2021-03-01 to 2021-05-31	188,616	shares	92
2020-09-01 to 2021-05-31	187,918	shares	273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2022-03-01 to 2022-05-31	-0.09	USD/shares	92
2021-09-01 to 2022-05-31	-0.27	USD/shares	273
2021-03-01 to 2021-05-31	4.22	USD/shares	92
2020-09-01 to 2021-05-31	5.94	USD/shares	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2022-05-31	2,876	USD
At 2021-08-31	598	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2022-03-01 to 2022-05-31	-1,595,378	USD	92
2021-09-01 to 2022-05-31	-3,738,811	USD	273
2021-03-01 to 2021-05-31	-47,097	USD	92
2020-09-01 to 2021-05-31	-160,549	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2022-05-31	820,406	USD
At 2021-08-31	168,476	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2022-05-31	29,523,664	USD
At 2021-08-31	406,725	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2022-05-31	133,578	USD
At 2021-08-31	41,874	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2022-03-01 to 2022-05-31	1,595,378	USD	92
2021-09-01 to 2022-05-31	3,738,811	USD	273
2021-03-01 to 2021-05-31	47,097	USD	92
2020-09-01 to 2021-05-31	162,208	USD	273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2022-05-31	0	USD
At 2021-08-31	17,000	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2022-03-01 to 2022-05-31	0	USD	92
2021-09-01 to 2022-05-31	0	USD	273
2021-03-01 to 2021-05-31	0	USD	92
2020-09-01 to 2021-05-31	1,659	USD	273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2022-03-01 to 2022-05-31	0	USD	92
2021-09-01 to 2022-05-31	0	USD	273
2021-03-01 to 2021-05-31	0	USD	92
2020-09-01 to 2021-05-31	1,421	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2022-05-31	20,020,239	shares
At 2021-08-31	188,616	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2022-05-31	47,375,512	USD
At 2021-08-31	2,745,906	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2022-05-31	533,738	USD
At 2021-08-31	0	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit
At 2022-05-31	350,099	USD
At 2022-01-01	619,825	USD
At 2021-08-31	0	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2022-05-31	35,555	USD
At 2021-08-31	2,056	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2021-09-01 to 2022-05-31	3,628,782	USD	273
2020-09-01 to 2021-05-31	-1,116,837	USD	273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2022-03-01 to 2022-05-31	-1,797,447	USD	92
2021-09-01 to 2022-05-31	-4,140,812	USD	273
2021-03-01 to 2021-05-31	796,156	USD	92
2020-09-01 to 2021-05-31	1,116,837	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2022-03-01 to 2022-05-31	19,855	USD	92
2021-09-01 to 2022-05-31	50,518	USD	273
2021-03-01 to 2021-05-31	14,831	USD	92
2020-09-01 to 2021-05-31	36,697	USD	273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2022-03-01 to 2022-05-31	261	USD	92
2021-09-01 to 2022-05-31	261	USD	273
2021-03-01 to 2021-05-31	299	USD	92
2020-09-01 to 2021-05-31	1,115	USD	273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2022-03-01 to 2022-05-31	848,613	USD	92
2021-09-01 to 2022-05-31	1,697,226	USD	273
2021-03-01 to 2021-05-31	0	USD	92
2020-09-01 to 2021-05-31	0	USD	273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2022-03-01 to 2022-05-31	14,498	USD	92
2021-09-01 to 2022-05-31	-110,029	USD	273
2021-03-01 to 2021-05-31	-843,253	USD	92
2020-09-01 to 2021-05-31	-1,277,386	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2021-09-01 to 2022-05-31	-401,627	USD	273
2020-09-01 to 2021-05-31	103,485	USD	273

Inspect the source

Entity: INNOVATION1 BIOTECH INC. / CIK 0001629205
Captured: 2026-09-21T17:21:04.610Z
SEC response SHA-256: c5f3acfa863971b33b185130c620366a2f45cfd805cf4850d8be9be21b48d8fb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001629205.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))